Digital Media Net - Your Gateway To Digital media Creation. News and information on Digital Video, VR, Animation, Visual Effects, Mac Based media. Post Production, CAD, Sound and Music
Categories: News

Loar Holdings Inc. Announces Date and Time for Third Quarter 2025 Earnings Conference Call

WHITE PLAINS, NEW YORK / ACCESS Newswire / November 5, 2025 / Loar Holdings Inc. (NYSE:LOAR), will report Q3 2025 earnings before the market opens on Wednesday, November 12, 2025.

A conference call will follow at 10:00a.m., Eastern Time. To participate in the call telephonically please dial +1 877-407-0670 / +1 215-268-9902. International participants can find a list of toll-free numbers here. A live audio webcast will also be available at the following link as well as through the Investor section of Loar Holdings website; https://ir.loargroup.com

The webcast will be archived and available for replay later in the day.

About Loar Holdings Inc.

Loar Holdings Inc. is a diversified manufacturer and supplier of niche aerospace and defense components that are essential for today’s aircraft and aerospace and defense systems. Loar has established relationships across leading aerospace and defense original equipment manufacturers and Tier Ones worldwide.

Contact

Ian McKillop
Loar Holdings Inc. Investor Relations
IR@loargroup.com

SOURCE: Loar Group Inc.

View the original press release on ACCESS Newswire

Staff

Recent Posts

Alpha1 AI Expands Support for Federal Agencies

Scholar, Spark and Resolve are already advancing agency-focused workforce learning, institutional knowledge and guided problem-solving,…

11 hours ago

Statement of Lanny J. Davis, Counsel to Kingsbarn Realty Capital

LAS VEGAS, NV / ACCESS Newswire / August 28, 2026 / Over the last six…

11 hours ago

Norsemont Announces Restatement of Financial Statements

VANCOUVER, BC / ACCESS Newswire / August 28, 2026 / Norsemont Mining Inc. (CSEX:NOM)(OTCQX:NRRSF)(FRA:LXZ1) ("NOM"…

11 hours ago

BEACN Announces Financial Results for the Second Quarter of 2026

Not for distribution to United States Newswire Services or for dissemination in the United States…

11 hours ago

Protagonist Therapeutics Announces U.S. FDA Approval of Hepcidin Mimetic Peptide MIMRYLO(TM) (rusfertide) for Polycythemia Vera

MIMRYLO™ is the First and Only Hepcidin Mimetic Peptide Therapy Approved for the Treatment of…

11 hours ago

IP Strategy Receives Nasdaq Notification Regarding Delayed Form 10-Q Filing

GIG HARBOR, WA / ACCESS Newswire / August 28, 2026 / IP Strategy Holdings, Inc.…

11 hours ago